BlackRock Fund Advisors - RXI PHARMACEUTICALS CORP NEW ownership

RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 26 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q1 2016$4,000
-20.0%
14,759
+24.7%
0.00%
Q4 2015$5,00011,8330.00%
Other shareholders
RXI PHARMACEUTICALS CORP NEW shareholders Q4 2015
NameSharesValueWeighting ↓
Broadfin Capital, LLC 5,018,409$1,355,0000.13%
TWO SIGMA SECURITIES, LLC 14,471$4,0000.01%
Virtu KCG Holdings LLC 160,446$43,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 1,646$00.00%
BANK OF AMERICA CORP /DE/ 16,000$5,0000.00%
WELLS FARGO & COMPANY/MN 171$00.00%
NORTHERN TRUST CORP 12,744$3,0000.00%
UBS Group AG 22,559$6,0000.00%
CITIGROUP INC 28$00.00%
GOLDMAN SACHS GROUP INC 19,616$5,0000.00%
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders